TNF and inflammatory bowel disease: However, there was no significant difference in the risk of RSV infection between patients on thiopurines or methotrexate (aOR, 1.012; 95% CI, 0.421–2.434) and anti-TNF (aOR, 1.009; 95% CI, 0.419–2.426) when compared with the IBD non-SARS-CoV-2 control cohort.